Drug prices

FDA approves another new migraine medicine

A phone with the Eli Lilly logo on the screen.
Eli Lilly has two prominent migraine drugs now. Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration has approved Reyvow, a new pill made by Eli Lilly that treats migraine attacks. The drugmaker did not immediately disclose the drug's price.

The big picture: Reyvow is not approved for the prevention of migraines, but other new drugs on the market — Aimovig, Ajovy and Emgality — are described as preventative for migraines.

Trump's smoke-and-mirrors 2020 health care strategy

Illustration of President Donald Trump presenting a levitating red cross with his fingers crossed behind his back
Illustration: Sarah Grillo/Axios

President Trump may be telling voters everything that they want to hear when it comes to health care, but much of it isn't true.

Why it matters: Trump is claiming victories he hasn't achieved and making promises he's not prepared to live up to, all on an immensely personal subject that voters consistently rank as one of the most important issues of 2020.